Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Stem Cell Res ; 67: 103027, 2023 03.
Article de Anglais | MEDLINE | ID: mdl-36640474

RÉSUMÉ

Overexpression of Ovarian Carcinoma Immunoreactive Antigen Domain containing protein 2 (OCIAD2) was carried out in BJNhem20 human Embryonic Stem Cell line (hESC). A stable line was generated through nucleofection of the plasmid construct pCAG-OCIAD2.


Sujet(s)
Cellules souches embryonnaires humaines , Humains , Cellules souches embryonnaires humaines/métabolisme , Lignée cellulaire , Plasmides , Différenciation cellulaire , Protéines tumorales/métabolisme
2.
Stem Cell Res ; 67: 103026, 2023 03.
Article de Anglais | MEDLINE | ID: mdl-36642056

RÉSUMÉ

Ovarian Carcinoma Immunoreactive Antigen domain containing 2 (OCIAD2) was knocked out by targeting its exon 4 through CRISPR-Cas9 paired nickase strategy to generate two OCIAD2 knockout human embryonic stem cell lines- one homozygous (BJNhem20-OCIAD2-CRISPR-33) and one heterozygous (BJNhem20-OCIAD2-CRISPR-40) for mutant ociad2. Both lines maintain pluripotency, normal karyotype, and trilineage differentiation potential.


Sujet(s)
Cellules souches embryonnaires humaines , Humains , Cellules souches embryonnaires humaines/métabolisme , Systèmes CRISPR-Cas , Techniques de knock-out de gènes , Caryotype , Cellules souches embryonnaires/métabolisme , Protéines tumorales/métabolisme
3.
Aging Cell ; 21(4): e13570, 2022 04.
Article de Anglais | MEDLINE | ID: mdl-35289070

RÉSUMÉ

Aging of the blood system is characterized by increased hematopoietic stem cells (HSCs) and myeloid-biased differentiation leading to higher propensity for hematological malignancies. Unraveling cell-intrinsic mechanisms regulating HSC aging could aid reversal or slowing of aging. Asrij/OCIAD1 is an evolutionarily conserved regulator of hematopoiesis and governs mitochondrial, endosomal, and proteasomal function in mammalian stem cells. Asrij deletion in mice causes loss of HSC quiescence, myeloid skewing, reduced p53 and increased DNA damage, features attributed to aged HSCs. Mechanistically, Asrij controls p53 ubiquitination and degradation and AKT/STAT5 activation. Asrij localizes to endosomes and mitochondria. As decline in organelle structure and function are common hallmarks of aging, we asked whether Asrij regulates organelle function in aged HSCs. We find that chronologically aged wild-type (WT) HSCs had reduced Asrij levels. Expectedly, young asrij KO mice had reduced AcH4K16 levels; however, transcriptome analysis of KO HSCs showed a modest overlap of gene expression with aged WT HSCs. Further, analysis of organelle structure and function in asrij KO mice revealed significant changes, namely damaged mitochondria, elevated ROS; impaired endosomal trafficking seen by increased cleaved Notch1, reduced Rab5; and reduced 26S proteasome activity. Pharmacological correction of mitochondrial and proteasome activity in asrij KO mice restored HSC and myeloid cell frequencies. Furthermore, lysophosphatidic acid-induced Asrij upregulation in aged WT mice rescued mitochondrial and proteasome activity and restored HSC frequency. Our results highlight a new role for Asrij in preventing HSC aging by regulating organelle homeostasis and will help decipher organelle dynamics in HSC longevity.


Sujet(s)
Proteasome endopeptidase complex , Protéine p53 suppresseur de tumeur , Vieillissement , Animaux , Hématopoïèse , Cellules souches hématopoïétiques/métabolisme , Mammifères , Souris , Organites/métabolisme , Proteasome endopeptidase complex/métabolisme , Protéine p53 suppresseur de tumeur/génétique , Protéine p53 suppresseur de tumeur/métabolisme
4.
Front Cell Dev Biol ; 9: 643444, 2021.
Article de Anglais | MEDLINE | ID: mdl-34295888

RÉSUMÉ

Mitochondria are highly dynamic organelles whose activity is an important determinant of blood stem and progenitor cell state. Mitochondrial morphology is maintained by continuous fission and fusion and affects stem cell proliferation, differentiation, and aging. However, the mechanism by which mitochondrial morphology and dynamics regulate cell differentiation and lineage choice remains incompletely understood. Asrij/OCIAD1 is a conserved protein that governs mitochondrial morphology, energy metabolism and human embryonic stem cell (hESC) differentiation. To investigate the in vivo relevance of these properties, we compared hESC phenotypes with those of Drosophila hematopoiesis, where Asrij is shown to regulate blood progenitor maintenance by conserved mechanisms. In concordance with hESC studies, we found that Drosophila Asrij also localizes to mitochondria of larval blood cells and its depletion from progenitors results in elongated mitochondria. Live imaging of asrij knockdown hemocytes and of OCIAD1 knockout hESCs showed reduced mitochondrial dynamics. Since key regulators of mitochondrial dynamics actively regulate mitochondrial morphology, we hypothesized that mitochondrial fission and fusion may control progenitor maintenance or differentiation in an Asrij-dependent manner. Knockdown of the fission regulator Drp1 in Drosophila lymph gland progenitors specifically suppressed crystal cell differentiation whereas depletion of the fusion regulator Marf (Drosophila Mitofusin) increased the same with concomitant upregulation of Notch signaling. These phenotypes were stronger in anterior progenitors and were exacerbated by Asrij depletion. Asrij is known to suppress Notch signaling and crystal cell differentiation. Our analysis reveals that synergistic interactions of Asrij with Drp1 and Marf have distinct impacts on lymph gland progenitor mitochondrial dynamics and crystal cell differentiation. Taken together, using invertebrate and mammalian model systems we demonstrate a conserved role for Asrij/OCIAD1 in linking mitochondrial dynamics and progenitor differentiation. Our study sets the stage for deciphering how regulators of mitochondrial dynamics may contribute to functional heterogeneity and lineage choice in vertebrate blood progenitors.

5.
Int J Dev Biol ; 64(1-2-3): 213-225, 2020.
Article de Anglais | MEDLINE | ID: mdl-32659010

RÉSUMÉ

Over the last two decades, an exponential growth in technologies and techniques available to biologists has provided mind-boggling quantities of data and led to information overload. Yet, answers to fundamental questions such as "how are we made?" and "what keeps us ticking?" remain incomplete. Developmental biology has provided elegant approaches to address such questions leading to enlightening insights. While several important contributions to developmental biology have come from India over the decades, this area of research remains nascent. Here, we review the journey in India, from the discovery of the ociad gene family to decoding its role in development and stem cells. We compare analysis in silico, in vivo and ex vivo, with developmental models such as Drosophila, mouse and stem cells that gave important insight into how these clinically significant genes function.


Sujet(s)
Biologie du développement , Protéines F-box/métabolisme , Régulation de l'expression des gènes au cours du développement , Protéines tumorales/métabolisme , Cellules souches/cytologie , Animaux , Protéines F-box/génétique , Humains , Protéines tumorales/génétique , Cellules souches/métabolisme
6.
Biofactors ; 44(3): 224-236, 2018 May.
Article de Anglais | MEDLINE | ID: mdl-29411439

RÉSUMÉ

Cellular stress like ER and oxidative stress are the principle causative agents of various proteinopathies. Multifunctional protein PARK7/DJ-1 provides protection against cellular stress. Recently, insulin/IGF also has emerged as a neuro-protective molecule. However, it is not known whether DJ-1 and insulin/IGF complement each other for cellular protection in response to stress. In this study, we show for the first time, that in human and mouse neuronal cell lines, down regulation of DJ-1 for 48 h leads to compensatory upregulation of insulin/IGF signaling (IIS) pathway genes, namely, insulin receptor, insulin receptor substrate, and Akt under normal physiological conditions as well as in cellular stress conditions. Moreover, upon exogenous supply of insulin there is a marked increase in the IIS components both at gene and protein levels leading to down regulation and inactivation of GSK3ß. By immunoprecipitation, it was observed that Sirt3 mediated deacetylation and activation of FoxO3a could not occur under DJ-1 downregulation. Transient DJ-1 downregulation also led to Akt mediated increased phosphorylation and nuclear exclusion of FoxO3a. When DJ-1 was downregulated increased interaction of Sirt3 with IRS2 was observed leading to its activation resulting in IIS upregulation. Thus, transient downregulation of DJ-1 leads to stimulation of IIS pathway by Sirt3 mediated IRS2 activation. Consequently, antiapoptotic program is triggered in neuronal cells via Akt-GSK3ß-FoxO3a axis. © 2018 BioFactors, 44(3):224-236, 2018.


Sujet(s)
Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Substrats du récepteur à l'insuline/métabolisme , Insuline/pharmacologie , Neurones/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Sirtuine-3/métabolisme , Animaux , Antigènes CD/génétique , Antigènes CD/métabolisme , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Protéine O3 à motif en tête de fourche/génétique , Protéine O3 à motif en tête de fourche/métabolisme , Régulation de l'expression des gènes , Glycogen synthase kinase 3 beta/génétique , Glycogen synthase kinase 3 beta/métabolisme , Humains , Peroxyde d'hydrogène/antagonistes et inhibiteurs , Peroxyde d'hydrogène/pharmacologie , Insuline/métabolisme , Substrats du récepteur à l'insuline/génétique , Facteur de croissance IGF-I/génétique , Facteur de croissance IGF-I/métabolisme , Souris , Neurones/cytologie , Neurones/effets des médicaments et des substances chimiques , Phosphorylation , Protein deglycase DJ-1/antagonistes et inhibiteurs , Protein deglycase DJ-1/génétique , Protein deglycase DJ-1/métabolisme , Protéines proto-oncogènes c-akt/génétique , Protéines proto-oncogènes c-akt/métabolisme , Petit ARN interférent/génétique , Petit ARN interférent/métabolisme , Récepteur à l'insuline/génétique , Récepteur à l'insuline/métabolisme , Transduction du signal , Sirtuine-3/génétique , Tunicamycine/antagonistes et inhibiteurs , Tunicamycine/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE